Tag

Spago Nanomedical

Tumorad Emil Aaltonen

Positive preclinical results from Spago Nanomedical

January 25, 2022

Spago Nanomedical has announced new …

Tumorad

Spago’s Tumorad shows good safety in preclinical studies

December 13, 2021

Spago Nanomedical has completed the …

Mats Hansen SpagoPix

Second dose group fully recruited in Spago Nanomedical study

December 2, 2021

Spago Nanomedical has annouced that …

Mats Hansen SpagoPix

Spago Nanomedical receives extended patent protection in Europe

December 8, 2020

Spago Nanomedical has received notice …

Tumorad

Spago Nanomedical appoints candidate drug in the Tumorad project

August 25, 2020

The company has decided to …

Tumorad

Spago Nanomedical’s Tumorad patent approved in Japan

April 24, 2020

Spago Nanomedical has received notice …

Mats Hansen SpagoPix

Spago Nanomedical has paused patient recruitment to clinical trial

April 20, 2020

Spago Nanomedical has momentarily halted …

Mats Hansen SpagoPix

New data from Spago Nanomedical

March 24, 2020

Data from the first dose …

Mats Hansen SpagoPix

Spago Nanomedical initiates new clinical trial

August 26, 2019

The company has conducted site …

Spago Nanomedical Research

Spago Nanomedical receives patent approval

August 13, 2019

The European Patent Office (EPO) …

Mats Hansen SpagoPix

Interview: Spago Nanomedical – Aiming to improve cancer care

June 13, 2019

The company recently reached an …

spago-nanomedical

Promising results for Spago Nanomedical

February 23, 2017

Collective data from recently completed …